Pharmaniaga Berhad (KLSE:PHARMA)
0.7400
-0.0200 (-2.63%)
At close: Nov 20, 2026
Pharmaniaga Berhad Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Pharmaniaga Berhad stock has a consensus rating of "Buy" and an average price target of RMĀ 1.45. The average 1-year stock price forecast is 96.35% higher than the current stock price, while the lowest is RMĀ 0.85 (+14.86%) and the highest is RMĀ 2.14 (+189.19%).
Price Target: RMĀ 1.45 (+96.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pharmaniaga Berhad stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
4.18B
from 3.93B
Increased by 6.55%
Revenue Next Year
4.32B
from 4.18B
Increased by 3.28%
EPS This Year
0.07
from 0.07
Decreased by -2.99%
EPS Next Year
0.07
from 0.07
Increased by 12.31%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.